CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.

Expression of CD44, a transmembrane hyaluronan-binding glycoprotein, is variably considered to have prognostic significance for different cancers, including oral squamous cell carcinoma. Although unclear at present, tissue-specific expression of particular isoforms of CD44 might underlie the differe...

Full description

Bibliographic Details
Main Authors: Abirami Rajarajan, Angela Stokes, Balvinder K Bloor, Rebecca Ceder, Hemini Desai, Roland C Grafström, Edward W Odell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3252301?pdf=render
_version_ 1828431038206967808
author Abirami Rajarajan
Angela Stokes
Balvinder K Bloor
Rebecca Ceder
Hemini Desai
Roland C Grafström
Edward W Odell
author_facet Abirami Rajarajan
Angela Stokes
Balvinder K Bloor
Rebecca Ceder
Hemini Desai
Roland C Grafström
Edward W Odell
author_sort Abirami Rajarajan
collection DOAJ
description Expression of CD44, a transmembrane hyaluronan-binding glycoprotein, is variably considered to have prognostic significance for different cancers, including oral squamous cell carcinoma. Although unclear at present, tissue-specific expression of particular isoforms of CD44 might underlie the different outcomes in currently available studies. We mined public transcriptomics databases for gene expression data on CD44, and analyzed normal, immortalized and tumour-derived human cell lines for splice variants of CD44 at both the transcript and protein levels. Bioinformatics readouts, from a total of more than 15,000 analyses, implied an increased CD44 expression in head and neck cancer, including increased expression levels relative to many normal and tumor tissue types. Also, meta-analysis of over 260 cell lines and over 4,000 tissue specimens of diverse origins indicated lower CD44 expression levels in cell lines compared to tissue. With minor exceptions, reverse transcribed polymerase chain reaction identified expression of the four main isoforms of CD44 in normal oral keratinocytes, transformed lines termed DT and HaCaT, and a series of paired primary and metastasis-derived cell lines from oral or pharyngeal carcinomas termed HN4/HN12, HN22/HN8 and HN30/HN31. Immunocytochemistry, Western blotting and flow cytometric assessments all confirmed the isoform expression pattern at the protein level. Overall, bioinformatic processing of large numbers of global gene expression analyses demonstrated elevated CD44 expression in head and neck cancer relative to other cancer types, and that the application of standard cell culture protocols might decrease CD44 expression. Additionally, the results show that the many variant CD44 exons are not fundamentally deregulated in a diverse range of cultured normal and transformed keratinocyte lines.
first_indexed 2024-12-10T17:57:30Z
format Article
id doaj.art-511ffbf83fab489a8fe51505c419a0b3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T17:57:30Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-511ffbf83fab489a8fe51505c419a0b32022-12-22T01:38:54ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0171e2877610.1371/journal.pone.0028776CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.Abirami RajarajanAngela StokesBalvinder K BloorRebecca CederHemini DesaiRoland C GrafströmEdward W OdellExpression of CD44, a transmembrane hyaluronan-binding glycoprotein, is variably considered to have prognostic significance for different cancers, including oral squamous cell carcinoma. Although unclear at present, tissue-specific expression of particular isoforms of CD44 might underlie the different outcomes in currently available studies. We mined public transcriptomics databases for gene expression data on CD44, and analyzed normal, immortalized and tumour-derived human cell lines for splice variants of CD44 at both the transcript and protein levels. Bioinformatics readouts, from a total of more than 15,000 analyses, implied an increased CD44 expression in head and neck cancer, including increased expression levels relative to many normal and tumor tissue types. Also, meta-analysis of over 260 cell lines and over 4,000 tissue specimens of diverse origins indicated lower CD44 expression levels in cell lines compared to tissue. With minor exceptions, reverse transcribed polymerase chain reaction identified expression of the four main isoforms of CD44 in normal oral keratinocytes, transformed lines termed DT and HaCaT, and a series of paired primary and metastasis-derived cell lines from oral or pharyngeal carcinomas termed HN4/HN12, HN22/HN8 and HN30/HN31. Immunocytochemistry, Western blotting and flow cytometric assessments all confirmed the isoform expression pattern at the protein level. Overall, bioinformatic processing of large numbers of global gene expression analyses demonstrated elevated CD44 expression in head and neck cancer relative to other cancer types, and that the application of standard cell culture protocols might decrease CD44 expression. Additionally, the results show that the many variant CD44 exons are not fundamentally deregulated in a diverse range of cultured normal and transformed keratinocyte lines.http://europepmc.org/articles/PMC3252301?pdf=render
spellingShingle Abirami Rajarajan
Angela Stokes
Balvinder K Bloor
Rebecca Ceder
Hemini Desai
Roland C Grafström
Edward W Odell
CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
PLoS ONE
title CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
title_full CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
title_fullStr CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
title_full_unstemmed CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
title_short CD44 expression in oro-pharyngeal carcinoma tissues and cell lines.
title_sort cd44 expression in oro pharyngeal carcinoma tissues and cell lines
url http://europepmc.org/articles/PMC3252301?pdf=render
work_keys_str_mv AT abiramirajarajan cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT angelastokes cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT balvinderkbloor cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT rebeccaceder cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT heminidesai cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT rolandcgrafstrom cd44expressioninoropharyngealcarcinomatissuesandcelllines
AT edwardwodell cd44expressioninoropharyngealcarcinomatissuesandcelllines